Patents by Inventor David Briers

David Briers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250091309
    Abstract: A cupsole for footwear, said cupsole comprising at least a sidewall, a bottom surface and a central portion and wherein said sidewall circumscribes the central portion, said central portion having openings, preferably in the form of at least one honeycomb structure and wherein at least the sidewall and the bottom surface of the cupsole have a solid structure with no openings and wherein the complete cupsole is customized on the base of specific and measured data obtained directly from the user and printed in 1 single 3D printing step thereby using a thermoplastic polymer.
    Type: Application
    Filed: November 6, 2020
    Publication date: March 20, 2025
    Applicant: Huntsman International LLC
    Inventors: Hugo Verbeke, David Briers, Bram Vanroy, Sandra Meynen
  • Publication number: 20240156821
    Abstract: The present invention relates to combination therapies for treating KRas G12C cancers. In particular, the present invention relates to methods of treating cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a combination of a an agent that blocks Programmed Death-1 receptor (PD-1) and Programmed Death Ligand-1 (PD-L1) signaling and a KRAS G12C inhibitor of Formula (I), Formula I-A or Formula I-B, kits comprising the compositions and methods of use therefor.
    Type: Application
    Filed: December 18, 2023
    Publication date: May 16, 2024
    Inventors: David Briere, James Gail Christensen, Peter Olson
  • Patent number: 11890285
    Abstract: The present invention relates to combination therapies for treating KRas G12C cancers. In particular, the present invention relates to methods of treating cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a combination of a an agent that blocks Programmed Death-1 receptor (PD-1) and Programmed Death Ligand-1 (PD-L1) signaling and a KRAS G12C inhibitor of Formula (I), Formula I-A or Formula I-B, kits comprising the compositions and methods of use therefor.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: February 6, 2024
    Assignee: Mirati Therapeutics, Inc.
    Inventors: David Briere, James Gail Christensen, Peter Olson
  • Patent number: 11814539
    Abstract: A cross-linkable powder for use in a selective laser sintering (SLS) process for additive manufacturing is disclosed as well as a novel manufacturing process to form a 3D object using said cross-linkable powder. The manufacturing process makes it possible to create interlayer covalent bondings between deposited layers of cross-linkable powder such that 3D printed objects are achieved having improved mechanical strength, less object deformation and/or no warping.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: November 14, 2023
    Assignee: HUNTSMAN INTERNATIONAL LLC
    Inventors: Hugo Verbeke, Bram Vanroy, David Briers
  • Publication number: 20220243059
    Abstract: A liquid curable polyurethane based resin comprising a) polyurethane compounds which are functionalized with reactive ethylenically unsaturated moieties, b) at least one reactive diluent compound having at least one ethylenically unsaturated functional group and c) at least one photo-initiator for making polymerized/cured polyurethane based materials having elongation at break values of >100%, preferably >125%, most preferably >150% and a tensile strength of >5 MPa, more preferably >7 MPa, most preferably >10 MPa (both measured according to DIN 53504 S2).
    Type: Application
    Filed: June 11, 2020
    Publication date: August 4, 2022
    Inventors: Hugo Verbeke, David Briers, Bram Vanroy, Sandra Meynen
  • Patent number: 11326027
    Abstract: A method for producing a hydroxyl-functionalized polysiloxane having secondary or tertiary hydroxyl groups, said method comprising the steps of: i) reacting a hydroxyalkyl allyl ether having a secondary or tertiary alcohol group with a siloxane under anhydrous conditions and under transition metal catalysis, said hydroxylalkyl allyl ether conforming to Formula (I) wherein n is 0, 1, 2, 3, 4 or 5, preferably 0; m is 1, 2, 3, 4 or 5, preferably 1; spacer group A is constituted by a covalent bond or a C1-C20 alkylene group; R1 is hydrogen, a C1-C8 alkyl group, a C3-C10 cycloalkyl group, a C6-C18 aryl group or an aralkyl group; Ra, Rb, Rc, Rd, R2, R3, R4 and R5 may be the same or different and each is independently selected from hydrogen, a C1-C8 alkyl group, a C6-C18 aryl group or a C6-C18 aralkyl group, with the proviso that at least one of R3 and R4 is not hydrogen; and said siloxane conforming to Formula (II) wherein m is 1, 2, 3, 4 or 5, preferably 1; R6, R7, R8 and R9 may be
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: May 10, 2022
    Assignee: Henkel AG & Co. KGaA
    Inventors: Marleen Winterberg, Marta Woznicka, Annika Dietrich, Esteban Mejia, Udo Kragl, Christina Despotopoulou, Ralf Dunekake, David Briers, Johann Klein, Henrik Lund
  • Publication number: 20220041889
    Abstract: A cross-linkable powder for use in a selective laser sintering (SLS) process for additive manufacturing is disclosed as well as a novel manufacturing process to form a 3D object using said cross-linkable powder. The manufacturing process makes it possible to create interlayer covalent bondings between deposited layers of cross-linkable powder such that 3D printed objects are achieved having improved mechanical strength, less object deformation and/or no warping.
    Type: Application
    Filed: December 19, 2019
    Publication date: February 10, 2022
    Inventors: Hugo Verbeke, Bram Vanroy, David Briers
  • Publication number: 20210085683
    Abstract: The present invention relates to combination therapies for treating KRas G12C cancers. In particular, the present invention relates to methods of treating cancer in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a combination of a an agent that blocks Programmed Death-1 receptor (PD-1) and Programmed Death Ligand-1 (PD-L1) signaling and a KRAS G12C inhibitor of Formula (I), Formula I-A or Formula I-B, kits comprising the compositions and methods of use therefor.
    Type: Application
    Filed: September 23, 2020
    Publication date: March 25, 2021
    Inventors: David Briere, James Gail Christensen, Pete Olson
  • Publication number: 20190322808
    Abstract: A method for producing a hydroxyl-functionalized polysiloxane having secondary or tertiary hydroxyl groups, said method comprising the steps of: i) reacting a hydroxyalkyl allyl ether having a secondary or tertiary alcohol group with a siloxane under anhydrous conditions and under transition metal catalysis, said hydroxylalkyl allyl ether conforming to Formula (I) wherein n is 0, 1, 2, 3, 4 or 5, preferably 0; m is 1, 2, 3, 4 or 5, preferably 1; spacer group A is constituted by a covalent bond or a C1-C20 alkylene group; R1 is hydrogen, a C1-C8 alkyl group, a C3-C10 cycloalkyl group, a C6-C18 aryl group or an aralkyl group; Ra, Rb, Rc, Rd, R2, R3, R4 and R5 may be the same or different and each is independently selected from hydrogen, a C1-C8 alkyl group, a C6-C18 aryl group or a C6-C18 aralkyl group, with the proviso that at least one of R3 and R4 is not hydrogen; and said siloxane conforming to Formula (II) wherein m is 1, 2, 3, 4 or 5, preferably 1; R6, R7, R8 and R9 may be
    Type: Application
    Filed: June 14, 2019
    Publication date: October 24, 2019
    Inventors: Marleen Winterberg, Marta Woznicka, Annika Dietrich, Esteban Mejia, Udo Kragl, Christina Despotopoulou, Ralf Dunekake, David Briers, Johann Klein, Henrik Lund
  • Publication number: 20190085219
    Abstract: The present invention is related to an electrically conductive, hot-melt adhesive or molding composition, said composition comprising: a) a binding agent which comprises at least one (co)polymer selected from the group consisting of polyamide, thermoplastic polyamide, copolyamide, polyolefins, poly(meth)acrylates, polystyrene, polyurethanes, polyesters, ethylene copolymers, ethylene vinyl copolymers, styrenic block copolymers, polylactic acid, silicones, epoxies and polyols; and, b) a conductive filler comprising particles (p1) which have a mass median diameter (D50) of ?100 microns and which are selected from the group consisting of flakes, platelets, leaf-like particles, dendritic particles, rods, tubes, fibres, needles and mixtures thereof, wherein said composition has a melt viscosity of from 2500 to 25000 mPa·s as measured at 210° C. and is further characterized in that said particles (p1) constitute from 15 to 70 wt. %, by weight of the composition.
    Type: Application
    Filed: October 19, 2018
    Publication date: March 21, 2019
    Inventors: Jeffrey CAI, David Briers, Callum Poole, Gunther Dreezen, Anthony Chapman, Dale R. Starkey
  • Publication number: 20190031812
    Abstract: A silylated polyurethane obtainable by a process comprising the following steps: (a) reacting at least one polyol with at least one triisocyanate to form a hydroxyl-terminated polyurethane prepolymer, and (b) reacting said polyurethane prepolymer with at least one isocyanatosilane of the formula (1): OCN—R—Si—(X)m(R1)3-m, wherein m is 0, 1 or 2, each R1 is independently from each other a hydroxyl group, an alkoxy group having 1 to 10 carbon atoms, an acyloxy group having 1 to 10 carbon atoms, or —OCH(R2)COOR3, wherein R2 is hydrogen or an alkyl group having 1 to 4 carbon atoms and R3 is a straight-chain or branched alkyl group having 1 to 8 carbon atoms, each X is independently from each other and optionally substituted hydrocarbon group having 1 to 10 carbon atoms, which can be interrupted by at least one heteroatom, and R is a difunctional organic group, to endcap the hydroxyl groups on said prepolymer with said isocyanatosilane.
    Type: Application
    Filed: October 5, 2018
    Publication date: January 31, 2019
    Inventors: Ralf Baetzgen, Jan-Erik Damke, David Briers, Johann Klein
  • Patent number: 10118984
    Abstract: A silylated polyurethane obtainable by a process comprising the following steps: (a) reacting at least one polyol with at least one triisocyanate to form a hydroxyl-terminated polyurethane prepolymer, and (b) reacting said polyurethane prepolymer with at least one isocyanatosilane of the formula (1): OCN—R—Si—(X)m(R1)3?m, wherein m is 0, 1 or 2, each R1 is independently from each other a hydroxyl group, an alkoxy group having 1 to 10 carbon atoms, an acyloxy group having 1 to 10 carbon atoms, or —OCH(R2)COOR3, wherein R2 is hydrogen or an alkyl group having 1 to 4 carbon atoms and R3 is a straight-chain or branched alkyl group having 1 to 8 carbon atoms, each X is independently from each other and optionally substituted hydrocarbon group having 1 to 10 carbon atoms, which can be interrupted by at least one heteroatom, and R is a difunctional organic group, to endcap the hydroxyl groups on said prepolymer with said isocyanatosilane.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: November 6, 2018
    Assignee: Henkel AG & Co. KGaA
    Inventors: Ralf Bätzgen, Jan-Erik Damke, David Briers, Johann Klein
  • Patent number: 10059728
    Abstract: The present invention relates to a method for preparing functionalized cyclosiloxanes of Formula I, wherein R, R1, R2, m, n1 and n2 are as defined herein, comprising reacting (i) a cyclosiloxane of Formula II with (ii) a substituted acetylene of Formula III in the presence of a hydrosilylation catalyst. The invention further relates to methods for preparing biscyclosiloxanes by reacting the vinyl cyclosiloxanes obtained according to the described methods and the (bis)cyclosiloxanes obtainable according to the described methods.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: August 28, 2018
    Assignee: Henkel AG & Co. KGaA
    Inventors: David Briers, Johann Klein, Esteban Mejia, Udo Kragl, Ralf Dunekake, Marleen Winterberg, Jens Baumgard
  • Publication number: 20170362371
    Abstract: A silylated polyurethane obtainable by a process comprising the following steps: (a) reacting at least one polyol with at least one triisocyanate to form a hydroxyl-terminated polyurethane prepolymer, and (b) reacting said polyurethane prepolymer with at least one isocyanatosilane of the formula (1): OCN—R—Si—(X)m(R1)3-m, wherein m is 0, 1 or 2, each R1 is independently from each other a hydroxyl group, an alkoxy group having 1 to 10 carbon atoms, an acyloxy group having 1 to 10 carbon atoms, or —OCH(R2)COOR3, wherein R2 is hydrogen or an alkyl group having 1 to 4 carbon atoms and R3 is a straight-chain or branched alkyl group having 1 to 8 carbon atoms, each X is independently from each other and optionally substituted hydrocarbon group having 1 to 10 carbon atoms, which can be interrupted by at least one heteroatom, and R is a difunctional organic group, to endcap the hydroxyl groups on said prepolymer with said isocyanatosilane.
    Type: Application
    Filed: September 7, 2017
    Publication date: December 21, 2017
    Inventors: Ralf Bätzgen, Jan-Erik Damke, David Briers, Johann Klein
  • Publication number: 20170096438
    Abstract: The present invention relates to a method for preparing functionalized cyclosiloxanes of Formula I, wherein R, R1, R2, m, n1 and n2 are as defined herein, comprising reacting (i) a cyclosiloxane of Formula II with (ii) a substituted acetylene of Formula III in the presence of a hydrosilylation catalyst. The invention further relates to methods for preparing biscyclosiloxanes by reacting the vinyl cyclosiloxanes obtained according to the described methods and the (bis)cyclosiloxanes obtainable according to the described methods.
    Type: Application
    Filed: October 17, 2016
    Publication date: April 6, 2017
    Inventors: David Briers, Johann Klein, Esteban Mejia, Udo Kragl, Ralf Dunekake, Marleen Winterberg, Jens Baumgard
  • Patent number: 8969457
    Abstract: The present invention relates to a curable composition, which comprises a) at least one radiation-curable resin, b) at least one specific anti-oxidant and c) at least one photoinitiator salt. The invention further relates to a cured product made from the curable composition. The curable compositions and/or the cured products thereof are particularly suitable as laminating adhesives, sealants, and/or encapsulants for electronic or optoelectronic devices.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: March 3, 2015
    Assignee: Henkel AG & Co. KGaA
    Inventor: David Briers